FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to biotechnology and medicine, particularly to immunotherapeutic polypeptides containing neoepitopes, polynucleotides coding them and a method of producing antigen-specific T-cells.
EFFECT: invention provides additional anticancer therapeutic vaccines to ensure effective and sufficient processing and presentation of epitopes.
13 cl, 13 dwg, 15 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEOANTIGENS AND THEIR APPLICATION | 2019 |
|
RU2805196C2 |
| NEOANTIGENS AND THEIR USE | 2019 |
|
RU2813924C2 |
| T-CELL RECEPTOR CONSTRUCTS AND THEIR USE | 2019 |
|
RU2785954C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
| ARTIFICIAL ANTIGEN-PRESENTING CELLS AND METHODS FOR THEIR APPLICATION | 2018 |
|
RU2763798C1 |
| ISOLATED RECOMBINANT VIRUS BASED ON INFLUENZA VIRUS FOR INDUCING SPECIFIC IMMUNITY TO INFLUENZA VIRUS AND/OR PREVENTING DISEASES CAUSED BY INFLUENZA VIRUS | 2021 |
|
RU2813150C2 |
| THERAPEUTIC ANTI-CANCER NEOEPITOPE VACCINE | 2017 |
|
RU2782422C2 |
| NEOANTIGENS AND THEIR APPLICATION METHODS | 2017 |
|
RU2773273C2 |
| ANTIBODIES SPECIFIC FOR CD70 AND THEIR USE | 2019 |
|
RU2801093C2 |
| ANTI-INTERFERON BETA ANTIBODIES AND THEIR USE | 2017 |
|
RU2750454C2 |
